🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

4 big deal reports: TriNet stock soars on word of potential sale

Published 06/11/2023, 07:45 AM
© Reuters.
AMED
-
OPCH
-
BAM
-
CIR
-
KKR
-
TNET
-
NETW
-

Here is your Pro Recap of 4 head-turning deal dispatches you may have missed this week: TriNet considers a sale, merger deals at Network International/Brookfield, Circor/KKR, and Optum’s unsolicited offer to Amedisys.

InvestingPro subscribers got this news before anyone else. Start your 7-day trial to get on board.

TriNet soars on sale rumors

Trinet (NYSE:TNET) shares jumped more than 9% on Friday after Reuters reported that the online payroll services provider is considering selling the company, citing sources familiar with the matter.

According to the report, the company is in discussions with potential buyers, in collaboration with investment bank Morgan Stanley. However, both TriNet and Morgan Stanley declined to comment on the matter.

Last month, Needham initiated coverage on TriNet with a Buy rating and a price target of $115.00.

InvestingPro | Always Know First

Brookfield buys Network International for $3.7 billion

Network International Holdings (LON:NETW) shares gained more than 5% following the announcement, according to which Brookfield (NYSE:BAM) will acquire the leading credit card processor in the Middle East and Africa for $3.7 billion (£2.2B), as InvestingPro reported in real time. The acquisition is expected to close in Q3/23.

Amedisys surges on unsolicited offer from Optum amid existing deal with Option Care Health

Shares of Amedisys (NASDAQ:AMED) rose over 15% on Monday after revealing an unsolicited offer from Optum to purchase all of Amedisys' common stock in an all-cash deal at $100 per share. This comes after Amedisys already agreed to a merger with Option Care Health (NASDAQ:OPCH), as announced on May 3, 2023.

Amedisys' Board is evaluating Optum's proposal while adhering to the terms of the merger agreement with Option Care Health and has not deemed Optum's proposal to be a "Superior Proposal" as defined in the existing agreement.

Discussions with Optum are ongoing, but there's no guarantee they'll result in a transaction. The Amedisys Board’s recommendation in favor of the merger agreement with Option Care Health and the merger with Option Care Health continues to be in effect.

OPCH shares gained more than 7% this week.

Circor stock jumps on KKR's $1.6B acquisition announcement

CIRCOR International (NYSE:CIR) shares jumped around 50% on Monday after it was announced that the global investment giant KKR & Co (NYSE:KKR) will acquire all shares of Circor for $49 per share in cash.

The transaction is expected to close in Q4/23. Assuming the completion is successful, Circor will transition to a privately-held company, wholly owned by KKR’s investment funds.

Jump on the biggest news for your portfolio amid a barrage of market headlines: Always be the first to know with InvestingPro.

Start your free 7-day trial now.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.